HomeComparePUTKY vs PFE

PUTKY vs PFE: Dividend Comparison 2026

PUTKY yields 6.72% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PUTKY wins by $34949.08M in total portfolio value
10 years
PUTKY
PUTKY
● Live price
6.72%
Share price
$37.18
Annual div
$2.50
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34949.13M
Annual income
$33,978,372,579.30
Full PUTKY calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — PUTKY vs PFE

📍 PUTKY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPUTKYPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PUTKY + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PUTKY pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PUTKY
Annual income on $10K today (after 15% tax)
$571.54/yr
After 10yr DRIP, annual income (after tax)
$28,881,616,692.41/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PUTKY beats the other by $28,881,594,372.50/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PUTKY + PFE for your $10,000?

PUTKY: 50%PFE: 50%
100% PFE50/50100% PUTKY
Portfolio after 10yr
$17474.59M
Annual income
$16,989,199,419.01/yr
Blended yield
97.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

PUTKY
No analyst data
Altman Z
2.9
Piotroski
7/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PUTKY buys
0
PFE buys
8
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$PFE▲ Buy$1,001 - $15,0002026-02-10
Susan M. Collins🏛 Senate$PFE▲ Buy$15,001 - $50,0002026-02-03
James French Hill🏢 House$PFE▼ Sell$100,001 - $250,0002025-12-31
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-12-19
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-15
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-05
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-08-05
Lisa McClain🏢 House$PFE▲ Buy$1,001 - $15,0002025-07-16
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPUTKYPFE
Forward yield6.72%6.13%
Annual dividend / share$2.50$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%13.2%
Portfolio after 10y$34949.13M$49.6K
Annual income after 10y$33,978,372,579.30$26,258.71
Total dividends collected$34882.29M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PUTKY vs PFE ($10,000, DRIP)

YearPUTKY PortfolioPUTKY Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$12,045$1,344.81$9,153$693.39+$2.9KPUTKY
2$15,916$3,027.66$8,593$849.25+$7.3KPUTKY
3$24,508$7,477.84$8,336$1,066.78+$16.2KPUTKY
4$47,746$21,522.81$8,437$1,384.80+$39.3KPUTKY
5$129,464$78,375.68$9,013$1,875.40+$120.5KPUTKY
6$535,754$397,228.05$10,306$2,680.72+$525.4KPUTKY
7$3,645,840$3,072,582.63$12,820$4,101.38+$3.63MPUTKY
8$42,983,493$39,082,444.06$17,673$6,826.70+$42.97MPUTKY
9$907,247,946$861,255,608.59$27,543$12,591.86+$907.22MPUTKY
10$34,949,127,881$33,978,372,579.30$49,560$26,258.71+$34949.08MPUTKY

PUTKY vs PFE: Complete Analysis 2026

PUTKYStock

PT United Tractors Tbk, together with its subsidiaries, sells and rents heavy equipment in Indonesia. The company operates through six segments: Construction Machinery, Mining Contracting, Coal Mining, Gold Mining, Construction Industry, and Energy. It also distributes heavy equipment under the Komatsu, UD Trucks, Scania, Bomag, and Tadano names to mining, plantation, construction, and forestry sectors, as well as for industrial heavy equipment. In addition, it sells and leases tractors, generators, forklifts, and mini excavators, as well as sells commodity parts. Further, the company offers mining services that supports coal companies, such as mining design and implementation, preliminary assessment and feasibility studies, construction of infrastructure and plant, removal of overburden and waste, commercial production, expansion of mine/plant, reclamation and revegetation, and transshipment and marketing, as well as owns interests in various coal mine concessions with total estimated coal reserves of 63 million tons, as well as technical and construction services for building, civil, and maritime work. Additionally, it engages in the engineering, planning, assembling, and manufacturing components of machinery, tools, parts, and heavy equipment; provision of vessel construction and related repair services; provision of vessel charter and shipping, and reconditioning services for engines and components; operating power plants; concrete product businesses; fishery business; exploration, mining, and mineral processing of gold and silver; and manufacturing of heavy equipment components and attachments. The company was founded in 1972 and is headquartered in Jakarta Timur, Indonesia. PT United Tractors Tbk is a subsidiary of PT Astra International Tbk.

Full PUTKY Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this PUTKY vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PUTKY vs SCHDPUTKY vs JEPIPUTKY vs OPUTKY vs KOPUTKY vs MAINPUTKY vs JNJPUTKY vs MRKPUTKY vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.